Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03144531 · ClinicalTrials.gov registry record · NA
Sleep Intervention for Kids and Parents: A Self-Management Pilot Study
A NA study, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
NCT03144531: Completed NA study, sponsored by University of Washington.
NCT03144531 is a NA study that has completed, run by University of Washington. The registered enrollment target is 66 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03144531, a NA study, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
Study Summary
Behavioral intervention for 6-11 year children with persistent asthma and sleep disturbance and a parent with sleep disturbance.
Primary Outcome
Actigraphy
Interventions
- BEHAVIORAL Sleep Intervention for Kids and Parents (SKIP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2017-03-01 |
| Est. Completion | 2018-08-08 |
| Phase | NA |
What the finished NCT03144531 record still lists
NCT03144531 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which Sleep Intervention for Kids and Parents (SKIP) is the first listed.
NCT03144531 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03144531 about?
NCT03144531 is a clinical study titled "Sleep Intervention for Kids and Parents: A Self-Management Pilot Study". Behavioral intervention for 6-11 year children with persistent asthma and sleep disturbance and a parent with sleep disturbance.
What is the current status of trial NCT03144531?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2017-03-01. Estimated completion is 2018-08-08.
What interventions are being tested in trial NCT03144531?
The interventions under investigation include: Sleep Intervention for Kids and Parents (SKIP) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03144531?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03144531's enrollment target sits among peer trials
66 1139th of 2000 higher than 857 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI